- Home
- MATV vs AQST Comparison
MATV vs AQST Comparison
Compare MATV & AQST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | MATV | AQST |
|---|---|---|
| Founded | 1995 | 2004 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Paper | Biotechnology: Pharmaceutical Preparations |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 494.1M | 504.0M |
| IPO Year | 1996 | 2007 |
Fundamental Metrics
Financial Performance| Metric | MATV | AQST |
|---|---|---|
| Price | $9.34 | $4.29 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 5 |
| Target Price | N/A | ★ $9.00 |
| AVG Volume (30 Days) | 325.7K | ★ 1.1M |
| Earning Date | 05-06-2026 | 05-01-2026 |
| Dividend Yield | ★ 4.24% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $67,430,000.00 |
| Revenue This Year | $2.97 | $10.08 |
| Revenue Next Year | $4.20 | $49.60 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 0.77 |
| 52 Week Low | $5.46 | $2.22 |
| 52 Week High | $15.48 | $7.55 |
Technical Indicators
Market Signals| Indicator | MATV | AQST |
|---|---|---|
| Relative Strength Index (RSI) | 50.37 | 61.11 |
| Support Level | $8.02 | $3.70 |
| Resistance Level | $9.99 | $4.35 |
| Average True Range (ATR) | 0.42 | 0.14 |
| MACD | -0.00 | 0.01 |
| Stochastic Oscillator | 60.86 | 83.12 |
Price Performance
Historical ComparisonAbout MATV Mativ Holdings Inc.
Mativ Holdings Inc is a leader in specialty materials, solving its customers' complex challenges by engineering bold, inventive solutions that connect, protect, and purify the world. The company operates in two segments, namely Filtration & advanced Materials, focused on filtration media and components, developed films, coating and converting solutions, and extruded mesh products, and (2) Sustainable & Adhesive Solutions (SAS), focused on tapes, labels, liners, specialty paper, packaging, and healthcare solutions.
About AQST Aquestive Therapeutics Inc.
Aquestive Therapeutics Inc is a specialty pharmaceutical company engaged in developing and commercializing differentiated products to meet medical needs. Its later-stage product pipeline focuses on the treatment of diseases of the Central Nervous System (CNS), and an earlier-stage pipeline for the treatment of severe allergic reactions, including anaphylaxis. Its commercial product portfolio includes Suboxone, Emylif, Ondif, and Sympazan. The product pipeline includes Libervant Buccal Film, AQST-108. The majority of its revenue comes from the United States.